SOPHiA GENETICS (SOPH) Research & Development (2020 - 2025)

SOPHiA GENETICS has disclosed Research & Development across 6 years of filings, most recently posting -$8.5 million for Q4 2025.

• Research & Development for Q4 2025 came in at -$8.5 million, up 6.62% year-over-year; the trailing twelve-month figure through Dec 2025 was -$34.2 million (changed 0.44% YoY), and the FY2025 annual result was -$34.2 million, changed 0.44% from the prior year.
• Research & Development came in at -$8.5 million for Q4 2025 at SOPHiA GENETICS, down from -$8.1 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of -$6.2 million in Q1 2021 to a low of -$10.1 million in Q3 2022.
• The 5-year median for Research & Development is -$8.7 million (2023), against an average of -$8.4 million.
• Across the five-year window, Research & Development jumped 99.85% in 2021 and sank 53.32% in 2022, its largest moves.
• SOPHiA GENETICS's Research & Development stood at -$6.4 million in 2021, then slipped by 6.79% to -$6.8 million in 2022, then plunged by 43.73% to -$9.8 million in 2023, then advanced by 6.31% to -$9.1 million in 2024, then increased by 6.62% to -$8.5 million in 2025.
• The last three Research & Development figures came in at -$8.5 million (Q4 2025), -$8.1 million (Q3 2025), and -$8.5 million (Q2 2025), per Business Quant data.